Nova Eye Medical
Nova Eye Medical is a medical device company focused on developing and commercializing innovative technologies for the treatment of glaucoma. Their proprietary technologies, including the iTrack™ family of canaloplasty devices and the Molteno3® glaucoma drainage device, offer comprehensive treatment options for ophthalmologists. The company collaborates with surgeons and researchers to develop solutions that address unmet needs in glaucoma management.
Short position
Nova Eye Medical (ASX:EYE) has 0.01% of its shares on issue reported as short positions as of 2 Oct 2026, or about 28,623 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.17% in January 2025. EYE is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Nova Eye Medical (EYE) company profile
Profile, insiders and operations
Company
AI-generated research profile of Nova Eye Medical
EYE intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links